Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pioneer Pharma Co. Ltd.

www.pioneer-pharma.com

Latest From Pioneer Pharma Co. Ltd.

Deals Shaping The Medical Industry, January 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014.

BioPharmaceutical Medical Device

Singapore’s MerLion Starts Phase II European Finafloxacin Trials

MerLion will enroll as many as 258 patients across centers in Germany and Poland for patients requiring hospitalization for urinary tract infections and pyelonephritis, positive signs for a drug in-licensed by Alcon for North America.

BioPharmaceutical Singapore

Australia’s Avita Raises Cash For Phase III ReCell Trials For Skin Culture Technology

Australia’s Avita Medical received funding from private investors and the U.S. military for a skin culture technology treatment aimed at treating wounds and burns as well as sores developed by bed-ridden patients.

BioPharmaceutical Medical Device

Still Waiting To Launch In U.S., NovaBay Sees Big Opportunity For Advanced Wound Care In Southeast Asia

While getting ready to launch FDA-approved wound-healing product NeutroPhase in the U.S., NovaBay also has expanded a commercialization partnership with Pioneer Pharma to add 13 Southeast Asian countries and territories to a collaboration once exclusive to China.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Pioneer Pharma Co. Ltd.
  • Senior Management
  • XinZhou Li, Pres.
  • Contact Info
  • Pioneer Pharma Co. Ltd.
    Phone: 898 6683 6041
    No. 2 E. World Trade Rd. Block C
    Rm 2102-2103
    Haikou City, 570125
    China
UsernamePublicRestriction

Register